BASEL, SWITZERLAND--(Marketwire - February 13, 2008) - Basilea Pharmaceutica (SWX: BSLN) announces that the US Food and Drug Administration (FDA) determined that the Anti-Infective Drugs Advisory Committee meeting scheduled for February 28, 2008 will not be held, as provided for under the provisions of the amendment of Section 505 of the Federal Food, Drug, and Cosmetic Act.
